CD79A and infection: In contrast, EHV-1-specific mucosal IgA antibody concentrations do not significantly increase upon infection [15,24], and mucosal IgA did not neutralize EHV-1 in vitro [29], suggesting some role of mucosal IgA in the first line of defense but only minor contributions to adaptive immune responses during EHV-1 infection [29].